If someone walks into your office with heart disease and you as a physician dont try to treat it, thats malpractice, Seeley says
Filiadis, I
During a mean follow-up of 9.6 months, adults receiving an SGLT2 inhibitor had a lower risk for a CV event than those receiving a GLP-1 receptor agonist (HR = 0.92
They track everything
Brassard, S.L., Ahn, H.M., Cerit, H., Hye, T., Durham, E.L., Chang, R.S., Hall, J., Boukezzi, S., Goldstein, J.M., Dillon, D.G., Pizzagalli, D.A., Holsen, L.M
There's good support for patience here: time to therapeutic effect remains similar at roughly 8 to 12 weeks regardless of escalation speed, so patients don't sacrifice their treatment timeline by following gradual protocols